CNOT10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.384400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.382990E-01
Normal-vs-Stage2
6.191600E-02
Normal-vs-Stage3
5.222100E-02
Normal-vs-Stage4
5.443200E-01
Stage1-vs-Stage2
6.370800E-01
Stage1-vs-Stage3
9.882200E-02
Stage1-vs-Stage4
1.824830E-01
Stage2-vs-Stage3
8.019200E-03
Stage2-vs-Stage4
2.615800E-01
Stage3-vs-Stage4
2.340100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.613900E-02
Normal-vs-AfricanAmerican
1.493760E-01
Normal-vs-Asian
1.016040E-01
Caucasian-vs-AfricanAmerican
7.975000E-01
Caucasian-vs-Asian
9.695000E-01
AfricanAmerican-vs-Asian
7.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.032300E-02
Normal-vs-Female
7.057900E-02
Male-vs-Female
9.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.257600E-01
Normal-vs-Age(41-60Yrs)
1.185020E-01
Normal-vs-Age(61-80Yrs)
5.207500E-02
Normal-vs-Age(81-100Yrs)
1.287450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.217600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.715600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.279600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.354420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.231200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.874000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.646400E-02
Normal-vs-Daily Drinker
8.074200E-02
Normal-vs-Weekly Drinker
9.206200E-02
Normal-vs-Occasional Drinker
2.519000E-01
Normal-vs-Social Drinker
9.252200E-02
Non Drinker-vs-Daily Drinker
8.535600E-01
Non Drinker-vs-Weekly Drinker
7.506600E-01
Non Drinker-vs-Occasional Drinker
1.861630E-01
Non Drinker-vs-Social Drinker
5.855000E-01
Daily Drinker-vs-Weekly Drinker
6.284800E-01
Daily Drinker-vs-Occasional Drinker
1.451640E-01
Daily Drinker-vs-Social Drinker
4.725800E-01
Weekly Drinker-vs-Occasional Drinker
3.365000E-01
Weekly Drinker-vs-Social Drinker
8.199000E-01
Occasional Drinker-vs-Social Drinker
4.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.990200E-01
Normal-vs-Grade 2
7.187200E-01
Normal-vs-Grade 3
6.736600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.485180E-01
Grade 1-vs-Grade 3
4.470000E-02
Grade 1-vs-Grade 4
7.990200E-01
Grade 2-vs-Grade 3
2.631600E-01
Grade 2-vs-Grade 4
7.187200E-01
Grade 3-vs-Grade 4
6.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.698400E-02
Normal-vs-NonDiabetic
3.951900E-02
Diabetic-vs-NonDiabetic
6.654400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.462420E-01
Normal-vs-NoPancreatitis
5.204000E-02
Pancreatitis-vs-NoPancreatitis
6.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.231400E-01
Normal-vs-N1
5.993700E-02
N0-vs-N1
3.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.534000E-01
Normal-vs-TP53-NonMutant
1.845000E-01
TP53-Mutant-vs-TP53-NonMutant
1.105560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
